Marketing firm Publicis sued by Massachusetts AG for fueling pain meds epidemic and getting docs to prescribe more pain meds

 Massachusetts Attorney General Maura Health sued a global marketing company  Publicis for engaging in unfair and deceptive marketing schemes to help a pain medication maker to market and sell certain pain medications that are addictive painkillers. The work included creating sales training materials and emails and other information distributed to prescribers to...

Continue reading…

Drug maker Fresenius Kabi Oncology pays $50 million after guilty plea to destroying records before FDA plant inspection

Drugmaker Fresenius Kabi Oncology Limited (FKOL) was sentenced to pay $50 million in fines and forfeiture after pleading guilty to concealing and destroying records prior to a 2013 U.S. Food and Drug Administration (FDA) plant inspection. The United States charged FKOL with violating the Federal Food, Drug and Cosmetic Act by failing to provide...
Continue reading…
Newman & Shapiro discusses the most common types of pharmaceutical fraud.

Common Types of Pharmaceutical Fraud

As part of the government’s efforts to reduce fraudulent behavior, it offers financial compensation to people who report certain types of fraud. These individuals, also known as “whistleblowers,” are an important source of information for the government, which is why it rewards them a portion of the proceeds it recovers in fraud...
Continue reading…

Johns Hopkins study finds that taking Tylenol while pregnant increases child risk for ADH or autism spectrum disorder by 3 times

A study from researchers at the Johns Hopkins found that exposure to acetaminophen (Tylenol) in the womb may increase a child’s risk for attention deficit hyperactivity disorder or autism spectrum disorder. The researchers analyzed data from the Boston Birth Cohort, a 20-year study of early life factors influencing pregnancy and child development....

Continue reading…

Reckitt Benckiser Group to pay $22.7 million to Kentucky in Medicaid fraud case for Suboxone administration without counseling

Reckitt Benckiser will pay $22.7 million in state and federal Medicaid dollars after reaching an agreement with a pharmaceutical distributor over its improper marketing and promotion of the drug Suboxone.

The civil settlement resolves allegations that, from 2010 through 2014, Reckitt, directly or through its subsidiaries, knowingly:

Continue reading…